Back to search

Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure

Data up to Jan 2025

Published1987
Citations44
References16

Total Citations Per Year

Abstract

References (16)

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

1983 • 295 citations

Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure

1974 • 247 citations

Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.

1983 • 192 citations

Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure

1980 • 178 citations

Tolerance to isosorbide dinitrate: rate of development and reversal.

1983 • 147 citations

Human pharmacological studies of a new transdermal system containing nitroglycerin

1982 • 140 citations

Hemodynamic effects of nitroglycerin ointment in congestive heart failure

1976 • 137 citations

Hemodynamic and Hormonal Response to Transdermal Nitroglycerin in Normal Subjects and in Patients With Congestive Heart Failure

1983 • 134 citations

Measurement of cardiac output during exercise by the thermodilution and direct fick techniques in patients with chronic congestive heart failure

1985 • 72 citations

Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure

1986 • 61 citations

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure

1985 • 57 citations

Nitroglycerin in a Transdermal Therapeutic System in Chronic Heart Failure

1984 • 56 citations

Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin

1984 • 56 citations

Pharmaceutical considerations of transdermal nitroglycerin delivery: The various approaches

1984 • 47 citations

Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.

1985 • 47 citations

Hemodynamic attenuation and the nitrate-free interval: Alternative dosing strategies for transdermal nitroglycerin

1985 • 22 citations

Cited By (0)

Loading...